UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors

This study has been completed.

Study NCT00036777 Information provided by National Cancer Institute (NCI)

First Received: May 13, 2002 Last Updated: July 23, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

Publications:

Hakimian RR, Edelman MJ, Bauer K, et al.: Phase I and pharmacokinetic (PK) study of the cyclin dependent kinase (CDK) inhibitor UCN-01 and carboplatin in solid tumors. [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-598, 149, 2003.